25016-09-5

Usage

Chemical Properties

Colorless to light yellow liquid

InChI:InChI=1/C6H8N2O/c1-5-3-6(4-9)8(2)7-5/h3-4H,1-2H3

Upstream product

• 10250-59-6 1,3-dimethyl-1H-pyrazole-5-carboxylic acid methyl ester 
• 57012-20-1 (1,3-dimethyl-1H-pyrazol-5-yl)methanol 

Downstream Products

• 499770-63-7 1-(1,3-dimethyl-1H-pyrazol-5-yl)methanamine 
• 1182280-64-3 N-(2,5-dimethyl-2H-pyrazol-3-ylmethyl)-4-(5-trifluormethyl-pyridin-2-yloxy)-benzenesulfonamide 
• 306936-77-6 1,3-dimethyl-1H-pyrazole-5-carbonitrile 
• 1255700-54-9 2-(2-(1,3-dimethyl-1H-pyrazol-5-yl)-8-(4-(2-methyl-1H-imidazol-1-yl)phenylamino)-2,3-dihydropyrido[3,2-f][1,4]oxazepin-4(5H)-yl)acetonitrile 
• 1604818-02-1 (2R,5S)-4-{2-[6-(2,4-difluorobenzyl)-3,3-dimethyl-2,3-dihydropyrrolo[3,2-b]pyridin-1-yl]-2-oxo-ethyl}-5-(2,5-dimethyl-2H-pyrazol-3-ylmethyl)-2-methyl-piperazine-1-carboxylic acid tert-butyl ester 
• 874278-15-6 C₂₇H₃₄N₆ 

Relevant academic research and scientific papers

SUBSTITUTED SULFONIC ACID AMIDE COMPOUNDS

The present invention relates to the use of substituted sulfonic acid amide compounds of formula I, wherein Ra, n, Het, A, Y and D are as defined in the claims and the N-oxides and the salts thereof for combating phytopathogenic harmful fungi,

Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them

The present invention provides, among other things, new bicyclo heterocyclic compounds, compositions comprising these heterocyclic compounds, methods of making the heterocyclic compounds, and methods of using these heterocyclic compounds for treating a variety of conditions and disease states associated with, for example, cellular proliferation, inflammation, glycosidase expression, or the low expression of Perlecan.

INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS

The present invention relates to compounds of Formula I: I which are agonists of the M-1 muscarinic receptor.